中国生物制药有限公司（01177）8月6日公告称，公司董事会拟于2026年8月19日（星期三）召开会议，主要议程包括： 1. 审议及批准公司及其附属公司截至2026年6月30日止六个月期间的未经审计中期业绩； 2. 研究及考虑派发2026年中期股息（如有）。
公告显示，公司董事会目前由11名董事组成，其中执行董事5名，分别为谢其润女士、谢炳先生、郑翔玲女士、谢承润先生及谢炘先生；独立非执行董事6名，分别为陆正飞先生、鲁红女士、张鲁夫先生、李国栋医生、陈列平博士及鲁白博士。
公司秘书赖娟代表董事会在公告中签署并发布上述消息。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.